MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters

References

1. 1.↵
   1. Scheithauer BW

   . Development of the WHO classification of tumors of the central nervous system: a historical perspective. Brain Pathol 2009;19:551–64 doi:10.1111/j.1750-3639.2008.00192.x pmid:18771526

   CrossRefPubMed
2. 2.↵
   1. Capper D,
   2. Jones DT,
   3. Sill M, et al

   . DNA methylation-based classification of central nervous system tumours. Nature 2018;555:469–74 doi:10.1038/nature26000 pmid:29539639

   CrossRefPubMed
3. 3.
   1. Sturm D,
   2. Orr BA,
   3. Toprak UH, et al

   . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–72 doi:10.1016/j.cell.2016.01.015 pmid:26919435

   CrossRefPubMed
4. 4.
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
5. 5.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106

   CrossRefPubMed
6. 6.↵
   1. Pajtler KW,
   2. Mack SC,
   3. Ramaswamy V, et al

   . The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol 2017;133:5–12 doi:10.1007/s00401-016-1643-0 pmid:27858204

   CrossRefPubMed
7. 7.
   1. Guerreiro Stucklin AS,
   2. Ramaswamy V,
   3. Daniels C, et al

   . Review of molecular classification and treatment implications of pediatric brain tumors. Curr Opin Pediatr 2018;30:3–9 doi:10.1097/MOP.0000000000000562 pmid:29315108

   CrossRefPubMed
8. 8.
   1. Jünger ST,
   2. Mynarek M,
   3. Wohlers I, et al

   . Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic feature: a retrospective analysis of the HIT ependymoma trial cohort. Acta Neuropathol Commun 2019;7:181 doi:10.1186/s40478-019-0820-5 pmid:31727173

   CrossRefPubMed
9. 9.↵
   1. Nowak J,
   2. Jünger ST,
   3. Huflage H, et al

   . MRI phenotype of RELA-fused pediatric supratentorial ependymoma. Clin Neuroradiol 2019;29:595–604 doi:10.1007/s00062-018-0704-2 pmid:30027327

   CrossRefPubMed
10. 10.
    1. Jaju A,
    2. Hwang EI,
    3. Kool M, et al

    . MRI features of histologically diagnosed supratentorial primitive neuroectodermal tumors and pineoblastomas in correlation with molecular diagnoses and outcomes: a report from the Children’s Oncology Group ACNS0332 trial. AJNR Am J Neuroradiol 2019;40:1796–1803 pmid:31601576

    PubMed
11. 11.
    1. Nowak J,
    2. Seidel C,
    3. Berg F, et al

    . MRI characteristics of ependymoblastoma: results from 22 centrally reviewed cases. AJNR Am J Neuroradiol 2014;35:1996–2001 doi:10.3174/ajnr.A4002 pmid:24948504

    CrossRefPubMed
12. 12.
    1. Stock A,
    2. Mynarek M,
    3. Pietsch T, et al

    . Imaging characteristics of wingless pathway subgroup medulloblastomas: results from the German HIT/SIOP-trial cohort. AJNR Am J Neuroradiol 2019;40:1811–17 doi:10.3174/ajnr.A6286 pmid:31649159

    CrossRefPubMed
13. 13.↵
    1. Nowak J,
    2. Nemes K,
    3. Hohm A, et al

    . Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor. Neuro Oncol 2018;20:1672–79 doi:10.1093/neuonc/noy111 pmid:30010851

    CrossRefPubMed
14. 14.↵
    1. Deng MY,
    2. Sill M,
    3. Sturm D, et al

    . Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC): a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol 2020;46:422–30 doi:10.1111/nan.12590 pmid:31867747

    CrossRefPubMed
15. 15.↵
    1. Pickles JC,
    2. Mankad K,
    3. Aizpurua M, et al

    . A case series of diffuse glioneuronal tumours with oligodendroglioma-like features and nuclear clusters (DGONC). Neuropathol Appl Neurobiol 2020;47:464–67 doi:10.1111/nan.12680 pmid:33325069

    CrossRefPubMed
16. 16.↵
    1. Holsten T,
    2. Lubieniecki F,
    3. Spohn M, et al

    . Detailed clinical and histopathological description of 8 cases of molecularly defined CNS neuroblastomas. J Neuropathol Exp Neurol 2021;80:52–59 doi:10.1093/jnen/nlaa128 pmid:33270865

    CrossRefPubMed